2009 pandemic H1N1 influenza A virus strains display differential pathogenicity in C57BL/6J but not BALB/c mice

Virulence

Volumn 2, Issue 6, 2011, Pages 563-566

  Otte, Anna ^a   Gabriel, Gülsah ^a  

^a LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

Author keywords

2009 pandemic H1N1; BALB c mice; C57BL 6J mice; Influenza virus; Pathogenicity

Indexed keywords

2009 H1N1 INFLUENZA; ARTICLE; AVIAN INFLUENZA VIRUS; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CYTOKINE RESPONSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; GENETIC VARIABILITY; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; VIRUS STRAIN; VIRUS VIRULENCE;

EID: 82955168455     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.2.6.18148     Document Type: Article

References (30)

1. Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sci USA 2004; 101:4620-4; http://dx.doi.org/10.1073/pnas.0308001101.
2. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. Avian flu: influenza virus receptors in the human airway. Nature 2006; 440:435-6; http://dx.doi.org/10.1038/440435a.
3. Gabriel G, Dauber B, Wolff T, Planz O, Klenk HD, Stech J. The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc Natl Acad Sci USA 2005; 102:18590-5; http://dx.doi.org/10.1073/pnas.0507415102.
4. Salomon R, Franks J, Govorkova EA, Ilyushina NA, Yen HL, Hulse-Post DJ, et al. The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/ Vietnam/1203/04. J Exp Med 2006; 203:689-97; http://dx.doi.org/10.1084/jem.20051938.
5. Gack MU, Albrecht RA, Urano T, Inn KS, Huang IC, Carnero E, et al. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 2009; 5:439-49; http://dx.doi.org/10.1016/j.chom.2009.04.006.
6. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009; 325:197-201; http://dx.doi.org/10.1126/science.1176225.
7. Pan C, Cheung B, Tan S, Li C, Li L, Liu S, et al. Genomic signature and mutation trend analysis of pandemic (H1N1) 2009 influenza A virus. PLoS ONE 2010; 5:9549; http://dx.doi.org/10.1371/journal.pone.0009549.
8. Lee RT, Santos CL, de Paiva TM, Cui L, Sirota FL, Eisenhaber F, et al. All that glitters is not gold-founder effects complicate associations of flu mutations to disease severity. Virol J 2010; 7:297; http://dx.doi.org/10.1186/1743-422X-7-297.
9. Preliminary review of D222G amino acid substitution in the haemagglutinin of pandemic influenza A (H1N1) 2009 viruses. Wkly Epidemiol Rec 2010; 85:21-2.
10. Liu Y, Childs RA, Matrosovich T, Wharton S, Palma AS, Chai W, et al. Altered receptor specificity and cell tropism of D222G hemagglutinin mutants isolated from fatal cases of pandemic A(H1N1) 2009 influenza virus. J Virol 2010; 84:12069-74; http://dx.doi.org/10.1128/JVI.01639-10
11. Ding X, Jiang L, Ke C, Yang Z, Lei C, Cao K, et al. Amino acid sequence analysis and identification of mutations under positive selection in hemagglutinin of 2009 influenza A (H1N1) isolates. Virus Genes 2010; 41:329-40; http://dx.doi.org/10.1007/s11262-010-0526-z.
12. Naffakh N, Tomoiu A, Rameix-Welti MA, van der Werf S. Host restriction of avian influenza viruses at the level of the ribonucleoproteins. Annu Rev Microbiol 2008; 62:403-24; http://dx.doi.org/10.1146/annurev.micro.62.081307.162746.
13. Bornholdt ZA, Prasad BV. X-ray structure of influenza virus NS1 effector domain. Nat Struct Mol Biol 2006; 13:559-60; http://dx.doi.org/10.1038/nsmb1099.
14. Herfst S, Chutinimitkul S, Ye J, de Wit E, Munster VJ, Schrauwen EJ, et al. Introduction of virulence markers in PB2 of pandemic swine-origin influenza virus does not result in enhanced virulence or transmission. J Virol 2010; 84:3752-8; http://dx.doi.org/10.1128/JVI.02634-09.
15. Safronetz D, Rockx B, Feldmann F, Belisle SE, Palermo RE, Brining D, et al. Pandemic swine-origin H1N1 influenza A virus isolates show heterogeneous virulence in macaques. J Virol 2011; 85:1214-23; http://dx.doi.org/10.1128/JVI.01848-10.
16. Boon AC, deBeauchamp J, Hollmann A, Luke J, Kotb M, Rowe S, et al. Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice. J Virol 2009; 83:10417-26; http://dx.doi.org/10.1128/JVI.00514-09.
17. Srivastava B, Blazejewska P, Hessmann M, Bruder D, Geffers R, Mauel S, et al. Host genetic background strongly influences the response to influenza a virus infections. PLoS ONE 2009; 4:4857; http://dx.doi.org/10.1371/journal.pone.0004857.
18. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 2000; 164:6166-73.
19. Salomon R, Hoffmann E, Webster RG. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc Natl Acad Sci USA 2007; 104:12479-81; http://dx.doi.org/10.1073/pnas.0705289104.
20. Liu Y, Chen H, Sun Y, Chen F. Antiviral role of tolllike receptors and cytokines against the new 2009 H1N1 virus infection. Mol Biol Rep 2011; In press.
21. Aldridge JR Jr, Moseley CE, Boltz DA, Negovetich NJ, Reynolds C, Franks J, et al. TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc Natl Acad Sci USA 2009; 106:5306-11; http://dx.doi.org/10.1073/pnas.0900655106.
22. To KK, Hung IF, Li IW, Lee KL, Koo CK, Yan WW, et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis 2010; 50:850-9; http://dx.doi.org/10.1086/650581.
23. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, et al. Emergence of a novel swineorigin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360:2605-15; http://dx.doi.org/10.1056/NEJMoa0903810.
24. Oughton M, Dascal A, Laporta D, Charest H, Afilalo M, Miller M. Evidence of viremia in 2 cases of severe pandemic influenza A H1N1/09. Diagn Microbiol Infect Dis 2011; 70:213-7; http://dx.doi.org/10.1016/j.diagmicrobio.2010.12.013.
25. Albright FS, Orlando P, Pavia AT, Jackson GG, Cannon Albright LA. Evidence for a heritable predisposition to death due to influenza. J Infect Dis 2008; 197:18-24; http://dx.doi.org/10.1086/524064.
26. Le Goffic R, Balloy V, Lagranderie M, Alexopoulou L, Escriou N, Flavell R, et al. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog 2006; 2:53; http://dx.doi.org/10.1371/journal.ppat.0020053.
27. Mibayashi M, Martinez-Sobrido L, Loo YM, Cardenas WB, Gale M Jr, Garcia-Sastre A. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol 2007; 81:514-24; http://dx.doi.org/10.1128/JVI.01265-06.
28. Gabriel G, Klingel K, Otte A, Thiele S, Hudjetz B, Arman-Kalcek G, et al. Differential use of importin- alpha isoforms governs cell tropism and host adaptation of influenza virus. Nat Commun 2011; 2:156; http://dx.doi.org/10.1038/ncomms1158.
29. Zúñiga J, Buendia I, Zhao Y, Jimenez L, Torres D, Romo J, et al. Genetic variants associated with severe pneumonia in A/H1N1 influenza infection. Eur Respir J 2011; In press; http://dx.doi.org/10.1183/09031936.00020611.
30. Tang YW, Li H, Wu H, Shyr Y, Edwards KM. Host single-nucleotide polymorphisms and altered responses to inactivated influenza vaccine. J Infect Dis 2007; 196:1021-5; http://dx.doi.org/10.1086/521370.